Newt Gingrich: No To Drug Price Controls, Yes To Price Transparency

Newt Gingrich: No To Drug Price Controls, Yes To Price Transparency

The problem in health care is not a lack of government control over prices. It is a lack of transparent prices altogether… The Most Favored Patient policy blueprint, developed by economists Steve Moore, Steve Forbes, and others, expands on price transparency and direct-to-patient drug sales to further simplify and bring accountability and affordability to the health care system. Supply-side reforms cannot work when consumers, employers, and prov…